Related Experiment Videos
Ocular hypotensive effect of ketanserin in patients with primary open angle glaucoma
L Mastropasqua1, C Costagliola, M Ciancaglini
1Institute of Ophthalmology, Chieti.
Acta Ophthalmologica Scandinavica. Supplement
|January 1, 1997
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Clinical evaluation of corneal elasticity and true IOP using a dual-applanation tonometer.
Frontiers in ophthalmology·2026
Effects of topical low-dose preservative-free hydrocortisone on intraocular pressure in patients affected by ocular surface disease with and without glaucoma.
Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie·2021
Consensus paper on postural dysfunction: recommendations for prevention, diagnosis and therapy.
Journal of biological regulators and homeostatic agents·2021
Nanoceria neuroprotective effects in the light-damaged retina: A focus on retinal function and microglia activation.
Experimental eye research·2019
Relationship between albuminuric CKD and diabetic retinopathy in a real-world setting of type 2 diabetes: Findings from No blind study.
Nutrition, metabolism, and cardiovascular diseases : NMCD·2019
Diabetic retinopathy, a vascular and inflammatory disease: Therapeutic implications.
Diabetes & metabolism·2019
Effect of brimonidine on patients undergoing uncontrolled IOP with beta-blockers.
Acta ophthalmologica Scandinavica. Supplement·2002
An unusual case of iris and lens colobomas: A case report.
Therapeutic advances in ophthalmology·2026
Transient monocular vertical hemifield loss as a rare acute oxaliplatin-induced ophthalmological side effect: a case report and review of the literature.
Therapeutic advances in drug safety·2026
Unveiling Otolith Mystery: Contemporary Testing Approaches and Their Clinical Significance.
World journal of otorhinolaryngology - head and neck surgery·2026
Transcriptomic profiling of thyroid eye disease orbital fibroblasts identifies sorafenib as a novel therapeutic.
Frontiers in endocrinology·2026